Special Populations: Pediatrics Arthur G. Roberts.

Slides:



Advertisements
Similar presentations
DISPOSITION OF DRUGS The disposition of chemicals entering the body (from C.D. Klaassen, Casarett and Doull’s Toxicology, 5th ed., New York: McGraw-Hill,
Advertisements

Selected Clinical Calculations
Kidney Function Tests Contents: Kidney functions Functional units Renal diseases Routine kidney function tests Serum creatinine Creatinine clearance.
Therapeutic Drug Monitoring (TDM)
CHAPTER 3 Life Span Considerations
Pharmacotherapy in the Elderly Paola S. Timiras May, 2007.
Pharmacotherapy in the Elderly Judy Wong
Kidney Function Tests Rana Hasanato, MD, KSFCB
Kidney Function Tests Contents: Functional units Kidney functions Renal diseases Routine kidney function tests Serum creatinine Creatinine clearance.
Renal Clearance The renal clearance of a substance is the volume of plasma that is completely cleared of the substance by the kidneys per unit time.
A seminar on ALTERED KINETICS IN RENAL DISEASES BY A.SRILATHA (M.Pharm I sem ) Department of Pharmaceutics BLUE BIRDS COLLEGE OF PHARMACY (Affiliated to.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 11 Drug Therapy in Geriatric Patients.
Objectives Describe the main physiological changes that occur with aging Identify factors affecting absorption and distribution with the geriatric client.
Dose Adjustment in Renal and Hepatic Disease
Drug Disposition Porofessor Hanan hager Dr.Abdul latif Mahesar College of medicine King Saud University.
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
Prof. Hanan Hagar Dr.Abdul latif Mahesar Pharmacology Department Pharmacokinetics III Concepts of Drug Disposition.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
Quantitative Pharmacokinetics
Kidney Function Tests. Kidney Function Tests Contents: Kidney functions Functional units Renal diseases Routine kidney function tests Serum creatinine.
Nonlinear Pharmacokinetics
RATIONAL DRUG THERAPY DR.SELVAN. INTRODUCTION Choosing a safe and effective treatment regimen for pediatric patients can be challenging. Multiple patient.
Kidney Function Tests.
Renal Excretion of Drugs
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
Pharmacology Department
Renal Excretion of Drugs Prof. Hanan Hagar Pharmacology Department.
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
CHLORAMPHENICOL First broad spectrum antibiotic. First broad spectrum antibiotic. Originally isolated in Originally isolated in Now produced.
VARIABILITY IN PHARMACOKINETICS & PATIENT RESPONSE Dr. Mohd B. Makmor Bakry, Ph.D., RPh Senior Lecturer in Clinical Pharmacy Universiti Kebangsaan Malaysia.
CLINICAL PHARMACY AGE FACTORS: FEATURES OF THE RATIONAL USE OF MEDICINES.
Factoid: Is there a difference in blood flow (Q) between an athlete and non- athlete? Blood flow increases during exercise. At rest, blood flow is similar.
Clearance Determinations Arthur G. Roberts. Routes of Elimination.
PHARMACOKINETICS Definition: quantitative study of drug absorption, distribution, metabolism, and excretion (ADME), and their mathematical relationship.
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
Renal Physiology and Function Part II Renal Function Tests
Concepts of drug disposition Pharmacology Department
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 3 Life Span Considerations.
Copyright ©2008 by Pearson Education, Inc. Upper Saddle River, New Jersey All rights reserved. Focus on Pharmacology, First Edition By Jahangir Moini.
Clinical Pharmacokinetic Equations and Calculations
Pharmacokinetics 2 General Pharmacology M212
Foundation Knowledge and Skills
DOSAGE ADJUSTMENT IN RENAL AND HEPATIC DISEASES Course Title : Biopharmaceutics and Pharmacokinetics – II Course Teacher : Zara Sheikh.
Drug efficacy is questioned.. Variation in drug responses.
Renal Excretion of Drugs Pharmacology Department
Lecture 29: Calculate GFR Infants – Normal: 2.0 mg/L (0.2 mg/dL) – Kidney Disease: >20.0 mg/L (2 mg/dL) Adults Males: 6-12 mg/L ( mg/dL) Females:
Basic Principles: PK By: Alaina Darby.
Drug therapy in pediatric
Kinetics Tutoring Allie Punke.
Excretion of drugs.
Pharmacokinetics: Pediatrics
Kidney Function Tests.
DRUGS USED IN PADEATRIC
Pharmacokinetics: Pediatrics
Drug Therapy in Pediatric Patients
URINE FORMATION.
Factors affecting Drug Activity
Pharmacokinetics & Drug Dosing
Pharmacokinetics and Factors of Individual Variation
Hawler Medical University
Basic Biopharmaceutics
Biopharmaceutics Chapter-6
SIVANAGESWARARAO MEKALA
Clinical Pharmacokinetics
Biopharmaceutics and pharmacokinetic by: Anjam Hama A. M. Sc
BIOAVAILABILITY.
Therapeutic Drug Monitoring
Medication Administration for Pediatrics
REFERENCE: APPLIED CLINICAL Slideshow by: lecturer HADEEL DELMAN
Drug Metabolism.
Presentation transcript:

Special Populations: Pediatrics Arthur G. Roberts

Is there a difference in blood flow (Q) between an athlete and non-athlete? Blood flow increases during exercise. At rest, blood flow is similar to non-athletes, except that it takes less beats/min to push the same amount of blood.

Review: Creatine Clearance Used to measure renal function and estimate glomulerular filtration rate (GFR) Creatine- breakdown product of creatinine, part of muscle Measure – blood and urine

Age Classifications Neonate- to 1 month post utero Infant- 1 month to 2 years Child- 2 and 12 years Pre-adolescent and adolescent- 13 to 17 years Adult- >18 years of age

Absorption Affected Gastric acid secretion Bile salt formation Gastric emptying time Intestinal motility Bowel length and effective absorptive surface Microbial flora

Effects on Absorption decrease in gastric pH – neonates, infants, young children – pH = 6-8 at birth (vaginal delivery, amniotic fluid) – increases to body weight ~2-3 years increase of basic drugs – penicillin decrease of weakly acidic drugs – phenytoin, phenobarbital

Effects on Absorption decrease gastric and intestinal motility (neonates and infants) – Peristalsis absent in first 2-4 days – Adult values reached in in 6-8 months – Prolonged diarrheal episodes may contribute decrease bile acids by 50% (neonates) – impaired absorption of lipid solubile drugs or vitamins.  -glucuronidase activity increases (breast milk)

Effects of Distribution: Body Composition

Effects on Distribution: Blood Volume Premature infants- 98 mL/kg At 1 year- 86 mL/kg > 1 year- 77 mL kg

Effects on Distribtuion Plasma Protein Binding – reduced Albumin (bilirubin and various drugs) Newborn- 3.1 g/dL (66% of adult) 1-3 years- 3.8 g/dL 4-6 years- 4.4 g/dL >7 years- 4.7 g/dL reduced affinity increased V d – reduced  -1-acid glycoprotein (orosomucoid) increased V d of basic drugs

Metablism and Elimination Liver metabolism – All enzymes, but activity reduced – Phase I (20-70%) of adult (neonate) reduced hydroxylation and N-demethylation capacity reduction the same increased methylation – Phase II reaches adult values in 3-4 years reduced conjugation – UGTs- chloramphenicol-”gray baby syndrome”

Metabolism and Elimination: Renal Clearance Creatine Clearance – (1 day)- 18 mL/min/1.73 m 2 – (6 days)- 36 mL/min/1.73 m 2 – (1-5 months) – 70 mL/min/1.73 m 2 – (6-11 months) – 100 mL/min/1.73 m 2 – (adult)-112 mL/min/1.73 m 2

Metabolism and Elimination: Renal Clearance Decreased renal function 20-40% of adult Decreased glomerular filtration rate – ~40 mL/min/1.73 m 2 (neonate) premature infants even lower Decreased Tubular Secretion and transporter- mediated Reabsorption Increased t 1/2, increase dosing interval

Estimating GFR (Creatine Clearance): Schwartz equations k = 0.33 in preemie infants k= 0.45 in infants to 1 year k = 0.55 to 13 years of age and female >13 years k=0.70 males >13 years renal-function

What the hell is 1.73 m 2 ? normalization refers to standardized body surface area of a 70 kg man – from 8 children, 7 adults in 1928 – areas of mean and women age 25 prior to actuarial tables

Aminoglycosides (Antibiotic) Streptomycin Gram-negative antibacterial therapeutic agent Examples Escherichia Coli (E. coli) Salmonella Shigella

Aminoglycosides: Baby’s Reaction Neonates – increased V d ( L/kg) (dosage?) – increased t 1/2 (dosing interval?) Infants and children – increased V d ( L/kg) (dosage?) – t 1/2 normalizes (dosing interval) Adults – V d ( L/kg) – t 1/2 (Streptomycin) = 3 hours – dosing interval = 8-12 hours

Aminoglycosides: Cystic Fibrosis Cystic fibrosis transmembrane conductance regulator (CFTR)

Aminoglycosides: Cystic Fibrosis Increased Vd – increased lean body mass/kg – increased tissue binding 25% Increased Cl, shorter t 1/2 (GFR) dosing? and dosing interval?

Vancomycin

Neonates – Increased Vd (0.75 L/kg) adult 0.62 L/kg – Increased T 1/ hours adults 4-6 hours Infants and children – Clearance 2-3x higher compared to adults – t 1/2 : 3-4 hours in infants – t 1/2 :2-3 hours in children

Digoxin (Lanoxin) Cardiomyocyte TN-C = Troponin C Foxglove known since the middle ages Control Heart Rate

Digoxin Neonates – Decreased Cl and Vd – Digoxin-like immunoreactive substance (DLIS) associated with cardiomyopathy structure similar to digoxin interferes with therapy baseline concentration may be required Infants – Increased Vd 11.9 L/kg Adult Vd 6L/kg

Digoxin Dosing

Theophylline caffeine PDE=Phosphodiesterase PKA=Protein Kinase A

Theophylline Indications in Pediatrics – Asthma – Premature apnea/bradycardia – Bronchopulmonary dysplasia Neonates – increased Vd, decreased Cl – lower loading and maintenance doses Children (1-4 years old) – increased Cl

Dosing